Quinupristin

This classification denotes an antibiotic with the molecular formula C53H67N9O10S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 23OW28RS7P, chemically known as virginiamycin s1, 4-(4-(dimethylamino)-n-methyl-l-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-l-2-piperidinecarboxylic acid)-, (s)- but more generally known as quinupristin, which bears U.S. National Institutes of Health Compound Identifier 71338. The European Medicines Agency schedules Quinupristin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10226MIG. The term QUINUPRISTIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, No. 3 1991, List 31). QUINUPRISTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(C1C2CCN(C1)CC2)CC1CN2C(CC1=O)C(=O)NC(C1CCCCC1)C(=O)OC(C(NC(=O)C1NCCCC1O)C(=O)NC(C(=O)N1C(CCC1)C(=O)N(C(C2=O)CC1CCC(N(C)C)CC1)C)CC)C.